Rapid Micro Biosystems, Inc. Class A
As of Oct 22, 2026, Rapid Micro Biosystems is in Stage 4, the downtrend phase, now in week 27 (since Apr 13, 2026). It closed at $0.80, 82.9% below its 52-week high and below its 200-day average, which is falling.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and p… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is RPID early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
RPID among Medical Devices104th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …104 | RPID | Stage 4 · wk 27 | 14 | −27.8% |
Rapid Micro Biosystems: quick answers
What stage is Rapid Micro Biosystems in?
As of Oct 22, 2026, Rapid Micro Biosystems (RPID) is in Stage 4, the downtrend phase. It entered Stage 4 on Apr 13, 2026 and is in week 27. What the four stages mean
Is Rapid Micro Biosystems in an uptrend?
No. Rapid Micro Biosystems is in a Stage 4 downtrend. It trades 65.4% below its 200-day average, which is falling.
How far is Rapid Micro Biosystems from its 52-week high?
Rapid Micro Biosystems closed at $0.80 on Oct 22, 2026, 82.9% below its 52-week high of $4.68. Its 52-week low is $0.76.
How has Rapid Micro Biosystems performed over the past year?
As of Oct 22, 2026, Rapid Micro Biosystems is down 72.7% over the past year and down 74.5% so far in 2026.
Which sector and industry is Rapid Micro Biosystems in?
Rapid Micro Biosystems is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.